On June 22, the U.S. House of Representatives approved a comprehensive opioid legislative package titled the Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (H.R. 6). The package serves as a legislative vehicle for the dozens of narrowly-focused opioid bills considered across multiple House committees in recent months.…Details
NACo has closely monitored the progress of opioid legislation moving through Congress. In view of the legislation’s potential impact for counties, NACo has released a working analysis of opioid bills under consideration in the House and Senate, as well as the projected impact for local governments addressing the epidemic. The chart of House legislation details…Details
On April 25, the U.S. House Energy and Commerce Health Subcommittee, chaired by Rep. Michael C. Burgess, M.D. (R-TX), advanced 57 bills to the full Energy and Commerce Committee. Of the bills, 56 were focused on ways to help combat the opioid crisis. #SubHealth also considered the bipartisan, bicameral reauthorization of the Animal Drug User Fee Act (ADUFA) and…Details
NLC Congressional City Conference Presentation: Resources for a Prevention Strategy – DEA Operation Prevention
During the National League of Cities’ 2018 Congressional City Conference, the Drug Enforcement Administration (DEA) presented on its Operation Prevention program, which aims to empower communities to recognize signs of addiction and how to address the issue. Click here to view the full presentation.
The Center on Budget and Policy Priorities (CBPP) recently released a policy brief on how Medicaid can be used as a tool to enhance patients’ access to critical treatment and mental health services. During a drug epidemic, these services are especially critical in treating substance use disorders (SUD). Medicaid is the nation’s largest payer for behavioral…Details